🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will establish whether prolonged chronic dosing with secukinumab...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2023-03-28
Trial ID
NCT05622708
Treatments Being Tested
The main objective of this study is to evaluate the efficacy and safety of ...
Status
Completed
Location
Advanced Research Associates - Glendale /ID# 204335
Start Date
2018-05-08
Trial ID
NCT03478787
Treatments Being Tested
Atopic Dermatitis, also known as atopic eczema, or eczema, is a common skin...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2015-11
Trial ID
NCT02594098
Treatments Being Tested
The purpose of this study is to compare the safety and efficacy of secukinu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-12-21
Trial ID
NCT04632927
Treatments Being Tested
The purpose of this study is to demonstrate the impact of secukinumab on th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-11-30
Trial ID
NCT03259074
Treatments Being Tested
The purpose of this study was to demonstrate efficacy of autoinjector admin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10-17
Trial ID
NCT01636687
Treatments Being Tested
This study is a multicenter, randomized, double-blind, parallel-arm, Phase ...
Status
Completed
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2022-10-26
Trial ID
NCT05377944
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of secu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-10-03
Trial ID
NCT02721966
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of secu...
Status
Completed
Location
Arizona Arthritis and Rheumatology Associates PLLC
Start Date
2023-03-22
Trial ID
NCT05767034
Treatments Being Tested
This study aims to examine the retention rate of secukinumab in adult patie...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2026-07-08
Trial ID
NCT07683065